Therapeutic archive
ISSN 0040-3660 (Print)
ISSN 2309-5342 (Online)
Menu
Archives
Home
About the Journal
Editorial Team
Editorial Policies
Author Guidelines
About the Journal
Issues
Search
Current
Archives
Contact
Editorial Board
All Journals
User
Username
Password
Remember me
Forgot password?
Register
Search
Search
Search Scope
All
Authors
Title
Abstract
Index terms
Full Text
Browse
By Issue
By Author
By Title
By Sections
Other Journals
×
User
Username
Password
Remember me
Forgot password?
Register
Search
Search
Search Scope
All
Authors
Title
Abstract
Index terms
Full Text
Browse
By Issue
By Author
By Title
By Sections
Other Journals
Home
>
Search
>
Author Details
Author Details
Titov, V
Issue
Section
Title
File
Vol 81, No 9 (2009)
Editorial
Treatment of patients with hypertriglyceridemia
Vol 82, No 4 (2010)
Editorial
Diagnosis of moderate and high hypertriglyceridemia in patients in polyclinic practice: primary and secondary lipid metabolic disturbances
Vol 82, No 10 (2010)
Editorial
Methylglyoxal is a test for biological dysfunctions of homeostasis and endoecology, low cytosolic glucose level, and gluconeogenesis from fatty acids
Vol 83, No 8 (2011)
Editorial
Modern conceptions of an uric acid role in development of essential hypertension
Vol 83, No 9 (2011)
Editorial
Relationship between a concentration of lipoprotein-associated secretory phospholipase A2 and markers of subclinical atherosclerotic lesion of arterial wall in patients with low and moderate risk by SCORE scale
Vol 84, No 9 (2012)
Editorial
Nonspecific inflammation and structural changes in the arteries of hypertensive males at high and moderate risk for cardiovascular events
Vol 85, No 9 (2013)
Editorial
Is there an association of uric acid level with preclinical target organ damage in moderate-and high-risk hypertensive patients?
Vol 86, No 9 (2014)
Editorial
Cystatin C and preclinical lesions in the target organs of hypertensive patients
Vol 87, No 9 (2015)
Editorial
Consecutive formation of the functions of high-, low-density and very-low-density lipoproteins during phylogenesis. Unique algorithm of the effects of lipid-lowering drugs
This website uses cookies
You consent to our cookies if you continue to use our website.
About Cookies
TOP